Skip to content
Governance Register

← US public companies

Metabasis Therapeutics INC

SEC CIK 1053221 · MBRX · last insider filing 2010-01-29

Directors (from insider filings)

NameCapacity as filedFilings
Evnin Luke Director filed 2006 - 2010
Hale David F Director filed 2006 - 2009
Laikind Paul K Director · President, CEO & Secretary filed 2006 - 2009
Stoner Elizabeth Director filed 2008 - 2009
Rohn William R Director filed 2006 - 2009
Oronsky Arnold L Director filed 2006 - 2009
Burgess Daniel D Director filed 2006 - 2009
Schreiner George Director filed 2007 - 2009
Gschwend Heinz W Director filed 2006 - 2006

Officers (from insider filings)

NameTitle as filedFilings
Nguyen Tran VP and CFO filed 2009 - 2009
Baracchini Edgardo Jr Sr. VP, Business Development filed 2006 - 2009
Erion Mark D Chief Scientific Officer filed 2006 - 2009
Millican Trisha Principal Accounting Officer filed 2008 - 2009
Gumbiner Barry VP Clinical Development & CMO filed 2008 - 2009
Foyt Howard Vice President filed 2006 - 2008
Beck John W Sr. VP, Finance & CFO filed 2006 - 2008
Frost Wayne VP of Regulatory Affairs & QA filed 2007 - 2007

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.